Gan, Zunyang – Trademark Portfolio

Entity Type: 01

Gan, Zunyang holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 6 filings in this category. Currently, 6 trademarks are registered. Notable registered marks include ANKDRT, ILOVEH, CECKAYD, OPOGOLR, and HIPKINSP. The owner is based in Guangdong Province.

No. 1604, Gelin Wangyuan, Huaqiangbei

Street, Futian District, Shenzhen City

Guangdong Province 518000 , CN

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ILOVEH
ILOVEH
Registered 2024
ANKDRT
ANKDRT
Registered 2022
OPOGOLR
OPOGOLR
Registered 2022
CECKAYD
CECKAYD
Registered 2022
HIPKINSP
HIPKINSP
Registered 2022
IPVFEETD
IPVFEETD
Registered 2022

Trademark Classifications

Gan, Zunyang's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (6 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Gan, Zunyang have?

Gan, Zunyang has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.

What trademark classes does Gan, Zunyang file in?

Gan, Zunyang files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Gan, Zunyang's most well-known trademarks?

Gan, Zunyang's registered trademark portfolio includes well-known marks such as ANKDRT, ILOVEH, CECKAYD, OPOGOLR, and HIPKINSP. These are among 6 currently registered trademarks in the portfolio.

What is Gan, Zunyang's trademark registration success rate?

Gan, Zunyang has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.